Roche third-quarter sales rise 3 percent, confirms outlook

ZURICH (Reuters) - Roche on Thursday confirmed its full-year outlook after third-quarter revenue rose 3 percent at constant exchange rates, helped by robust sales of drugs in its portfolio of medicines to fight cancer.